The reported statements, read against the company's own industry.
Financials view
Market Capitalization
1.21BUSD
vs all stocks (USD)
Updated Jul 19, 2026
Revenue (TTM)
10.90MUSD
vs all stocks (USD)
Updated Jul 19, 2026
Profit Margin
-1208.35%
Provider-reported. Net Income (TTM) ÷ Revenue (TTM) on this page gives -2111.09%.Updated Jul 19, 2026
Beta
2.51x
vs all stocks
Updated Jul 19, 2026
52-Week Change
-62.98%
vs all stocks
Updated Jul 19, 2026
Market Capitalization
1.21BUSD
vs all stocks (USD)
Updated Jul 19, 2026
Enterprise Value
1.75BUSD
vs all stocks (USD)
Updated Jul 19, 2026
Forward P/E
-7.58x
Updated Jul 19, 2026
Price to Book (MRQ)
147.44x
Updated Jul 19, 2026
Enterprise to Revenue
160.40x
Updated Jul 19, 2026
Enterprise to EBITDA
-12.38x
Updated Jul 19, 2026
Gross Margin
-660.70%
Provider-reported. Gross Profit (TTM) ÷ Revenue (TTM) on this page gives -970.49%.Updated Jul 19, 2026
Profit Margin
-1208.35%
Provider-reported. Net Income (TTM) ÷ Revenue (TTM) on this page gives -2111.09%.Updated Jul 19, 2026
Operating Margin
-1012.72%
Updated Jul 19, 2026
Return on Assets (TTM)
-12.73%
Updated Jul 19, 2026
Return on Equity (TTM)
-80.93%
Updated Jul 19, 2026
Revenue (TTM)
10.90MUSD
vs all stocks (USD)
Updated Jul 19, 2026
Revenue per Share (TTM)
0.0610USDUpdated Jul 19, 2026
Quarterly Revenue Growth
161.20%
Updated Jul 19, 2026
Gross Profit (TTM)
-105.80MUSD
vs all stocks (USD)
Updated Jul 19, 2026
EBITDA (TTM)
-141.29MUSD
vs all stocks (USD)
Updated Jul 19, 2026
Net Income (TTM)
-230.15MUSD
vs all stocks (USD)
Updated Jul 19, 2026
Quarterly Earnings Growth (YoY)
161.20%
Updated Jul 19, 2026
Operating Cash Flow (TTM)
-146.53MUSD
vs all stocks (USD)
Updated Jul 19, 2026
Levered Free Cash Flow (TTM)
-97.13MUSD
vs all stocks (USD)
Updated Jul 19, 2026
Trailing Annual Dividend Rate
0.00USDUpdated Jul 19, 2026
Trailing Annual Dividend Yield
0.00%
vs all stocks
Updated Jul 19, 2026
Payout Ratio
0.00%
Updated Jul 19, 2026
Revenue
8.36MUSDFY2025 · Dec 31, 2025
Cost of Goods Sold
109.31MUSDFY2025 · Dec 31, 2025
Gross Profit
-100.96MUSDFY2025 · Dec 31, 2025
Operating Income
-166.37MUSD
vs all stocks (USD)
FY2025 · Dec 31, 2025
Pre-tax Income
-181.59MUSDFY2025 · Dec 31, 2025
Income Tax Expense
970.00KUSDFY2025 · Dec 31, 2025
Net Income
-182.56MUSDFY2025 · Dec 31, 2025
EBIT
-117.15MUSDFY2025 · Dec 31, 2025
EBITDA (Income Statement)
-125.76MUSDFY2025 · Dec 31, 2025
Research & Development
5.92MUSDFY2025 · Dec 31, 2025
Selling, General & Administrative
59.48MUSDFY2025 · Dec 31, 2025
Non-operating Interest Income
5.86MUSDFY2025 · Dec 31, 2025
Non-operating Interest Expense
64.45MUSDFY2025 · Dec 31, 2025
Net Income from Continuing Operations
-182.56MUSDFY2025 · Dec 31, 2025
Operating Cash Flow
-113.00MUSDFY2025 · Dec 31, 2025
Free Cash Flow
-153.85MUSDFY2025 · Dec 31, 2025
Cash & Cash Equivalents (End of Period)
168.03MUSDFY2025 · Dec 31, 2025
Interest Paid
36.11MUSDFY2025 · Dec 31, 2025
Starting Profit (CF Statement)
-182.56MUSDFY2025 · Dec 31, 2025
Depreciation & Amortization
33.67MUSDFY2025 · Dec 31, 2025
Deferred Taxes (CF)
970.00KUSDFY2025 · Dec 31, 2025
Stock-based Compensation
14.94MUSDFY2025 · Dec 31, 2025
Other Non-cash Items
24.56MUSDFY2025 · Dec 31, 2025
Change in Accounts Receivable (CF)
-2.01MUSDFY2025 · Dec 31, 2025
Change in Accounts Payable (CF)
2.54MUSDFY2025 · Dec 31, 2025
Change in Other Assets/Liabilities
-5.10MUSDFY2025 · Dec 31, 2025
Capital Expenditures
-40.85MUSDFY2025 · Dec 31, 2025
Purchase of Investments
-13.62MUSDFY2025 · Dec 31, 2025
Sale of Investments
0.00USDFY2025 · Dec 31, 2025
Net Investing Cash Flow
-54.47MUSDFY2025 · Dec 31, 2025
Long-term Debt Issuance
51.80MUSDFY2025 · Dec 31, 2025
Long-term Debt Payments
-53.98MUSDFY2025 · Dec 31, 2025
Common Stock Repurchase
-4.93MUSDFY2025 · Dec 31, 2025
Other Financing Charges
-9.24MUSDFY2025 · Dec 31, 2025
Net Financing Cash Flow
317.12MUSDFY2025 · Dec 31, 2025
Shares Outstanding
180.84MSharesUpdated Jul 19, 2026
Float Shares
145.24MSharesUpdated Jul 19, 2026
Shares Short
53.25MSharesUpdated Jul 19, 2026
Short Ratio
7.26days
vs all stocks
Updated Jul 19, 2026
Short % of Shares Outstanding
36.54%
vs all stocks
Provider-reported. Shares Short ÷ Shares Outstanding on this page gives 29.45%.Updated Jul 19, 2026
% Held by Insiders
2.73%
vs all stocks
Updated Jul 19, 2026
% Held by Institutions
68.99%
vs all stocks
Updated Jul 19, 2026
Total Cash (MRQ)
121.09MUSD
vs all stocks (USD)
Updated Jul 19, 2026
Total Cash per Share (MRQ)
0.6700USDUpdated Jul 19, 2026
Total Debt (MRQ)
466.46MUSD
vs all stocks (USD)
Updated Jul 19, 2026
Total Debt to Equity (MRQ)
1.47x
Updated Jul 19, 2026
Current Ratio (MRQ)
1.71x
Updated Jul 19, 2026
Book Value per Share (MRQ)
0.0410USDUpdated Jul 19, 2026
Total Assets
922.67MUSD
vs all stocks (USD)
FY2025 · Dec 31, 2025
Total Current Assets
198.02MUSDFY2025 · Dec 31, 2025
Total Liabilities
876.78MUSDFY2025 · Dec 31, 2025
Total Non-current Assets
724.65MUSDFY2025 · Dec 31, 2025
Total Non-current Liabilities
789.21MUSDFY2025 · Dec 31, 2025
Total Current Liabilities
87.56MUSDFY2025 · Dec 31, 2025
Cash & Cash Equivalents
156.69MUSDFY2025 · Dec 31, 2025
Other Short-term Investments
13.63MUSDFY2025 · Dec 31, 2025
Accounts Receivable
2.01MUSDFY2025 · Dec 31, 2025
Inventory
9.37MUSDFY2025 · Dec 31, 2025
Accounts Payable
9.25MUSDFY2025 · Dec 31, 2025
Short-term Debt
17.08MUSDFY2025 · Dec 31, 2025
Other Current Liabilities
14.03MUSDFY2025 · Dec 31, 2025
Long-term Debt
402.05MUSDFY2025 · Dec 31, 2025
Other Non-current Liabilities
2.71MUSDFY2025 · Dec 31, 2025
Common Stock (Book)
180.00KUSDFY2025 · Dec 31, 2025
Retained Earnings
-815.94MUSDFY2025 · Dec 31, 2025
Total Shareholders' Equity
45.89MUSD
vs all stocks (USD)
FY2025 · Dec 31, 2025
52-Week Low
4.93USDUpdated Jul 19, 2026
52-Week High
17.28USDUpdated Jul 19, 2026
52-Week Change
-62.98%
vs all stocks
Updated Jul 19, 2026
Beta
2.51x
vs all stocks
Updated Jul 19, 2026
50-Day MA
9.64USDUpdated Jul 19, 2026
200-Day MA
9.21USDUpdated Jul 19, 2026
Avg 10-Day Volume
4.73MSharesUpdated Jul 19, 2026
Avg 30-Day Volume
6.51MSharesUpdated Jul 19, 2026
Diluted EPS (TTM)
-1.47USDUpdated Jul 19, 2026
Other Income / Expense
43.36MUSDFY2025 · Dec 31, 2025
2 interpretations currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
The price is falling, swinging wider than usual, and sits well below its peak.
Ulcer Index Elevated, Drawdown From Peak Significant, 20-Week Volatility Elevated
It sits well below its peak, and the fall has been both deep and long.
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Structural Tensions
Looks liquid, but the distress score says otherwiseNotable